Variant varicella-zoster viruses and methods of use

Details Variant varicella-zoster viruses and methods of use Variant varicella-zoster viruses and methods of use

2005-01-18

2005-01-18

Salimi, Ali R. (Department: 1648)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Virus or component thereof

C424S204100, C424S130100, C435S006120, C435S975000, C435S345000

Reexamination Certificate

active

06843997

ABSTRACT:
The present invention provides methods directed to detecting antibodies that specifically bind to a varicella zoster polypeptide, detecting the presence of a varicella zoster virus in an animal, diagnosing a disease caused by varicella zoster virus, and detecting a varicella zoster virus having a single nucleotide polymorphism in ORF68. The present invention also provides a vaccine composition, a method for producing a modified attenuated varicella zoster virus, isolated polynucleotides, and isolated polypeptides, and viruses.

REFERENCES:
patent: 3985615 (1976-10-01), Kubo
patent: 5462734 (1995-10-01), Letchworth, III et al.
patent: 5595890 (1997-01-01), Newton et al.
patent: 5710248 (1998-01-01), Grose et al.
patent: 5849476 (1998-12-01), Shiraki et al.
patent: 5952174 (1999-09-01), Nikiforov et al.
patent: 6087170 (2000-07-01), Kemble
patent: WO 9206989 (1992-04-01), None
Valcarcel et al, Vaccine, 1997, Vol. 15, No. 6/7, pp. 709-719.*
Wu et al., Archives of Virology, 1997, Vol 142, pp. 349-362.*
Fowler et al, Virology, 1995, Vol. 214, pp. 531-540.*
A. M. Arvin et al., “Live Attenuated Varicella Vaccine,”Annu. Rev. Microbiol., 50,59-100 (1996).
A. M. Arvin et al., “Immunity to Varicella-Zoster Viral Glycoproteins, gp I (gp 90/58) and gp III (gp 118), and to a Nonglycosylated Protein, p. 170,”J. Immunol. 137,1346-1351 (1986).
ATCC CCL-171, “Homo sapiens(human),” [online]. Retreived on May 16, 2001. Retrieved from the Internet; <URL:http://phage.atcc.org/cgi-bin/searchengine/longview.cgi!view=ce, 317407, CCL-171&ctext=CCL.-1,3 pages.
ATCC VR-586, “Variella-Zoster,” [online]. Retrieved on Jun. 5, 2001. Retrived from the Internet <URL:http//phage.atcc.org/cgi-bin/seachengine/longview.cgi!view=av,343894, VR-586&text=VR-586>, 2 pages.
ATCC VR-795, “Varicella-Zoster deposited as Varicella,” [online]. Retrieved on May 16, 2001. Retrieved from the Internet:<URL:http://phage.atcc.org/cgi-bin/searchengine/longview.cgi!view=av,476976, VR-795&text=VR-7.9>, 2 pages.
ATCC VR-916, “Varicella-Zoster deposited as Varicella,” [online]. Retrieved on Sep. 6, 2000. Retrieved from the Internet:<URL:http//phage.atcc.org/cgi-bin/searchengine/longview.cgi!view=av,554286&text=varicella>, 1 page.
ATCC VR-1367, “Varicella-Zoster,” [online]. Retrieved on Jun. 5, 2001. Retrieved from the Internet:<URL:http://phage.atcc.org/cgi-bin/searchengine/longview.cgi!view=av,871705, VR-1367&text=VR-1367>, 2 pages.
M. F. Bachman et al., “The influence of Antigen Organization on B Cell Responsiveness,”Science, 262,1448-1451 (1993).
R. E. Bergen et al., “Human T Cells Recognize Multiple Epitopes of an Immediate Early/Tegument Protein (IE62) and Glycoprotein I of Varicella Zoster Virus,”Viral Immunol., 4,151-166 (1991).
J. I. Cohen et al., “Generations of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro,”Proc. Natl. Acad. Sci. USA, 90,7376-7380 (1993).
N. L. Cole et al., “Colchicine treatment in the preparation of varicella-zoster virus inocula,”J. Virol. Methods, 36,111-118 (1992).
A. J. Davison et al., “The Complete DNA Sequence of Varicella-Zoster Virus,”J. Gen. Virol., 67,1759-1816 (1986).
K. S. Dingwell et al., “Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo across junctions of cultured cells,”J. Virol., 68834-845 (1994).
K. M. Duus et al., “Cell Surface Expression and Fusion by the Varicella-Zoster Virus gH:gL Glycoprotein Complex: Analysis by Laser Scanning Confocal Microscopy,”Virology, 210,429-440 (1995).
K. M. Duus et al., “Multiple Regulatory Effects of Varicella-Zoster Virus (VZV) gL on Trafficking Patterns and Fusogenic Properties of VZV gH,”J. Virol., 70,8961-8971 (1996).
J. R. Ecker et al., “Varicella zoster virus DNA exists as two isomers,”Proc. Natl. Acad. Sci. USA, 79,156-160 (1982).
T. Gojobori et al., “Rates of evolution of the retroviral oncogene of Maloney murine sarcoma virus and of its cellular homologues,”Proc. Natl. Acad. Sci. USA, 82,4198-4201 (1985).
F. L. Graham et al., “Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5,”J. Gen. Virol., 36,59-74 (1977).
C. Grose et al., “Computer modeling of prototypic and aberrant nucleocapsids of varicella-zoster virus,”Virology, 214,321-329 (1995).
C. Grose, “Glycoproteins Encoded by Varicella-Zoster Virus: Biosynthesis, Phosphorylation, and Intracellular Trafficking,”Annu. Rev. Microbiol., 44,59-80 (1990).
C. Grose, “Pathogenesis of Infection with Varicella Vaccine,”Infect. Dis. Clinics NA, 10,489-505 (1996).
C. Grose, et al., “Varicella-Zoster Virus: Isolation and Propagation in Human Melanoma Cells at 36 and 32°C.,”Infect. Immun. 19,199-203 (1978).
C. Grose, et al., “Monoclonal Antibodies Against Three Major Glycoproteins of Varicella-Zoster Virus,”Infect. Immun., 40,381-388 (1983).
C. Grose, “The Synthesis of Glycoproteins in Human Melanoma Cells Infected with Varicella-Zoster Virus,”Virology, 101:1-9 (1980).
B. H. Hahn et al., “Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS,”Science, 232,1548-1553 (1986).
R. Harson et al., “Egress of Varicella-Zoster Virus from the Melanoma Cell: a Tropism for the Melanocyte,”J. Virol., 69,4994-5010 (1995).
C. Hatfield et al., “Epitope Mapping and Tagging by Recombination PCR Mutagenesis,”Bio Techniques, 22,332-337 (1997).
J. Holland et al., “Rapid evolution of RNA genomes,”Science, 215,1577-1585 (1982).
M. Ito et al., “Human Leukocytes Kill Varicella-Zoster Virus-Infected Fibroblasts in the Presence of Murine Monoclonal Antibodies to Virus-Specific Glycoproteins,”J. Virol., 54,98-103 (1985).
D. H. Jones et al., “A Rapid Method for Site-Specific Mutagenesis and Directional Subcloning by Using the Polymerase Chain Reaction to Generate Recombinant Circles,”Bio Techniques, 8,178-183 (1990).
F. Jones et al., “Role of cytoplasmic vacuoles in varicella-zoster virus glycoprotein trafficking and virion envelopment,”J. Virol., 62,2701-2711 (1988).
P. R. Kinchington et al., “Regulated Nuclear Localization of the Varicella-Zoster Virus Major Regulatory Protein, IE62,”J. Infect. Dis., 178(Suppl. 1), S16-21 (1998).
P. R. Kinchington et al., “Molecular basis for a geographic variation of varicella-zoster virus recognized by a peptide antibody,”Neurology, 45(Suppl 8), S13-14 (1995).
P. LaRussa et al., “Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates,”J. Virol. 66,1016-1020 (1922).
V. Litwin et al., “Receptor Properties of Two Varicella-Zoster Virus Glycoproteins, gpI and gpIV, Homologous to Herpes Simplex Virus gE and gI,”J. Virol., 66,3643-3651 (1992).
V. Litwin et al., “Cell Surface Expression of the Varicella-Zoster Virus Glycoproteins and Fc Receptor,”Virology, 178,263-272 (1990).
S. Mallory et al., “Mutational Analysis of the Role of Glycoprotein I in Varicella-Zoster Virus Replication and Its Effect on Glycoprotein E Conformation and Trafficking,”J. Virol., 71,8279-8288 (1997).
D. J. McGeoch et al., “Molecular phylogeny of the alphaherpesvirinae subfamily and a proposed evolutionary timescale,”J. Mol. Biol., 238,9-22 (1994).
D. J. McGeoch et al., “Molecular phylogeny and evolutionary timescale for the family of mammalian herpesviruses,”J. Mol. Biol., 247,443-458 (1995).
J. F. Moffat et al., “Tropism of Varicella-Zoster Virus for Human CD4+and CD8+T Lymphocytes and Epidermal Cells in SCID-hu Mice,”J. Virol., 69,5236-5242 (199

Affiliated with

Also associated with

Rating

Variant varicella-zoster viruses and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Variant varicella-zoster viruses and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Variant varicella-zoster viruses and methods of use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3406409